These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12362262)

  • 1. Metastatic melanoma in a patient with Clouston syndrome successfully treated with isolated hyperthermic limb perfusion.
    Parhizkar N; Jones VE; McClay EF; Yi ES; Bouvet M
    J Cutan Med Surg; 2003; 7(1):43-6. PubMed ID: 12362262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities.
    Jönsson PE; Hafström L; Hugander A
    Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term results of a double perfusion schedule using high dose hyperthermia and melphalan sequentially in extensive melanoma of the lower limb.
    Noorda EM; Vrouenraets BC; Nieweg OE; Klaase JM; van der Zee J; Kroon BB
    Melanoma Res; 2003 Aug; 13(4):395-9. PubMed ID: 12883366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of regional and systemic toxicity of isolated hyperthermic extremity perfusion with tumor necrosis factor-alpha and melphalan].
    Hohenberger P; Haier J; Kettelhack C; Schulze G; Schlag PM
    Chirurg; 1997 Sep; 68(9):914-20. PubMed ID: 9410682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.
    Di Filippo F; Rossi CR; Santinami M; Cavaliere F; Garinei R; Anzà M; Perri P; Botti C; Di Angelo P; Pasqualoni R; Di Filippo S
    In Vivo; 2006; 20(6A):739-42. PubMed ID: 17203758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment.
    Hoekstra HJ; Schraffordt Koops H; de Vries LG; van Weerden TW; Oldhoff J
    Cancer; 1993 Aug; 72(4):1224-9. PubMed ID: 8393368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma.
    Kettelhack C; Kraus T; Hupp T; Manner M; Schlag P
    Eur J Surg Oncol; 1990 Aug; 16(4):370-5. PubMed ID: 2379595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermic antiblastic perfusion in the treatment of local recurrence or "in-transit" metastases of limb melanoma.
    Cavaliere R; Di Filippo F; Giannarelli D; Carlini S; Anzà M; Cavaliere F; Graziano F; Perri P
    Semin Surg Oncol; 1992; 8(6):374-80. PubMed ID: 1439448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-blastic hyperthermic perfusion in the treatment of melanoma of the extremities in the loco-regional diffusion phase].
    Di Filippo F; Garinei R; Anzà M; Cavaliere F; Botti C; Perri P; Di Filippo S
    Tumori; 2003; 89(4 Suppl):241-3. PubMed ID: 12903606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculating regional tissue volume for hyperthermic isolated limb perfusion: Four methods compared.
    Cecchin D; Negri A; Frigo AC; Bui F; Zucchetta P; Bodanza V; Gregianin M; Campana LG; Rossi CR; Rastrelli M
    Eur J Surg Oncol; 2016 Dec; 42(12):1898-1905. PubMed ID: 27005884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan.
    Lejeune FJ; Deloof T; Ewalenko P; Fruhling J; Jabri M; Mathieu M; Nogaret JM; Verhest A
    Recent Results Cancer Res; 1983; 86():268-76. PubMed ID: 6648008
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperthermic perfusion of extremities for melanoma and soft tissue sarcomas.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF; Gutierrez AA
    Recent Results Cancer Res; 1977; (59):171-85. PubMed ID: 408886
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
    van Ginkel RJ; Limburg PC; Piers DA; Koops HS; Hoekstra HJ
    Ann Surg Oncol; 2002 May; 9(4):355-63. PubMed ID: 11986187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    J Clin Oncol; 1996 Feb; 14(2):479-89. PubMed ID: 8636761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity.
    Storm FK; Morton DL
    Am J Surg; 1985 Jul; 150(1):32-5. PubMed ID: 4014570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.